🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,022 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8158617

Fused heterocyclic compound and use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8153694

Cyclopropanecarboxylic acid compound

Takeda Pharmaceutical Company Limited · Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8148367

Renin inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8143258

Benzothiazole compounds useful for Raf inhibition

Takeda Pharmaceutical Company Limited · Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8133898

Renin inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Mar 13 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8124617

Imidazopyridine compounds

Takeda Pharmaceutical Company Limited · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8124606

Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones

Takeda Pharmaceutical Company Limited · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8119655

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114620

Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases

Takeda Pharmaceutical Company Limited · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8110585

Bicyclic compound and pharmaceutical use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8105626

Granules containing acid-unstable chemical in large amount

Takeda Pharmaceutical Company Limited · Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8097737

Process for production of optically active amine derivatives

Takeda Pharmaceutical Company Limited · Granted Tue Jan 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093236

Weekly administration of dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093403

Process for producing fused imidazole compound, reformatsky reagent in stable form, and pr

Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8093382

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092830

Lactic acid polymer and process for producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088726

Process for producing sustained-release composition

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8088821

Fused cyclic compounds

Takeda Pharmaceutical Company Limited · Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8084058

Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Takeda Pharmaceutical Company Limited · Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071766

HSP90 inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8071130

Solid preparation

Takeda Pharmaceutical Company Limited · Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067030

Controlled release composition and method of producing the same

Takeda Pharmaceutical Company Limited · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8067453

Neurotrophin production/secretion promoting agent

Takeda Pharmaceutical Company Limited · Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8063066

MAPK/ERK kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted